Research & Development

Olon and Politecnico University launch research project

This strongly internationally oriented, three-year project involves a PhD program dedicated to the development of new knowledge

Breaking News

Curia reveals continuous-flow collaboration with Corning

Continuous flow chemistry is critical for the development and manufacture of pharmaceutical intermediates and APIs

Brenntag opens development centre in Singapore

Positioned as a Brenntag Pharma Centre of Excellence, it will be the company’s first Pharma R&D facility

Samsung Biologics commences construction on fifth plant

The company will invest over KRW 1.9 trillion in the new facility and break ground in the first half of this year

Pharma turns to CD8 in vivo imaging to predict response to immunotherapy

Improving the success rates of immunotherapy drugs has long been a difficult challenge. But finding ways to accurately measure the presence of CD8+...

Catalent and Grünenthal announce manufacturing collaboration

In this phase, Catalent supported Grünenthal with the development of a bioavailability enhanced formulation

CatSci's new partnership with AGC Pharma Chemicals

AGC Pharma Chemicals have more than 40 years of small molecule CDMO and 60 years of API manufacturing experienc

The ascent of smart labs for cell and gene therapies

The biotechnology industry has seen remarkable progress in the past decade, especially in the field of cell and gene therapy. These cutting-edge re...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

Teknova and Sartorious announce gene therapy collaboration

The collaboration highlights two essential components necessary for the successful recovery of empty and full AAV capsids during anion-exchange (AE...

Study reveals affects of low endotoxin biomaterials reliability in 3D in vitro models

The joint study done by the University of Twente, The Netherlands, and Rousselot Biomedical investigated for the first time the impact of endotoxin...

Pioneering a new era of gene therapy with sequencing innovation

Developing treatments for individuals with genetic diseases represents one of the most exciting frontiers in biomedical research, says Neil Ward, V...

Host cell protein analysis: strategies to improve sensitivity and reproducibility

Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstr...

Pfizer enters into merger with Seagen

The companies expect to complete the transaction in late 2023 or early 2024, subject to fulfilment of customary closing conditions

Six strategies to streamline early phase small molecule API discovery and development

Proactive planning during the early phases of API development can help to mitigate any challenges that might arise later. Mat Minardi, Executive Vi...

Calibre acquires AlphaScience

The company’s diagnostics product portfolio covers a wide variety of end market applications, including autoimmune, allergy, clinical chemistry and...

Personalised medicine: the future of the life sciences industry

Creating medicines that are specific to individual patients requires a lot of data that must be both available and secure, reports Greg Hookings, D...